U.S. Water Utilities Stock News

NasdaqCM:SGML
NasdaqCM:SGMLMetals and Mining

Sigma Lithium Supply Deal Resets Production Outlook And Investor Trade Offs

Sigma Lithium (NasdaqCM: SGML) has signed a significant supply agreement, securing long-term sales for its lithium products. The company has resumed its production cadence, including the commercialization of low grade lithium product. The agreement is supported by a sizable revolving working capital facility and a commercial partnership with a leading supply chain player. Sigma Lithium, listed on NasdaqCM under the ticker SGML, focuses on lithium production that supports battery and...
NYSE:AORT
NYSE:AORTMedical Equipment

How Artivion’s Return To Profitability And Device Demand At Artivion (AORT) Has Changed Its Investment Story

In February 2026, Artivion reported its fourth-quarter and full-year 2025 results, with revenue rising to US$115.99 million for the quarter and US$441.33 million for the year, and net income improving to US$2.43 million and US$9.77 million respectively, reversing prior-year losses. Beyond the headline return to profitability, management credited strong demand for stent grafts and the On-X mechanical heart valve, supported by fresh clinical data, while acknowledging lingering operational...
NasdaqGS:CWST
NasdaqGS:CWSTCommercial Services

Casella Waste Systems Pursues Deal Driven Growth As Margins Come Under Strain

Casella Waste Systems (NasdaqGS:CWST) has completed nine acquisitions, adding more than $115 million in annualized revenues. The company outlined an active pipeline of additional deals it aims to pursue in 2026. Management framed the acquisition push as a key lever for scaling operations and driving efficiencies across the business. For investors following NasdaqGS:CWST, this deal streak comes at a time when the stock is trading at $92.71 and has seen a 17.2% decline over the past year,...
NasdaqGS:FTRE
NasdaqGS:FTRELife Sciences

Will Fortrea (FTRE) Executive Shifts Refocus Its Clinical Margin Story Or Signal Strategic Drift?

On 17 February 2026, Fortrea Holdings expanded its executive team by dedicating Oren Cohen, MD solely to the chief medical officer role and appointing Scott Dove, PhD as president of Clinical Pharmacology Services, with both serving on the Executive Committee. This leadership reshaping concentrates seasoned medical and early development expertise at the top of the organization, potentially affecting how Fortrea runs trials and manages its clinical pharmacology operations. Next, we’ll examine...
NasdaqGS:SAIA
NasdaqGS:SAIATransportation

Saia Faces Volume Strain As Price Hikes And Investment Hit Returns

Saia (NasdaqGS:SAIA) is facing ongoing sales volume challenges over the last two years and has leaned on price increases to support revenue. At the same time, the company has stepped up investment activity, which has pressured cash flows. Returns on capital have declined, raising questions about whether Saia’s traditional profit drivers are maturing. Saia operates in the less than truckload freight sector, where pricing power and network efficiency matter as much as demand trends. For you...
NYSE:NTST
NYSE:NTSTRetail REITs

What NETSTREIT (NTST)'s US$209 Million Equity Raise and Dividend Hike Means For Shareholders

Earlier in February 2026, NETSTREIT Corp. completed a US$208.62 million follow-on equity offering of 10,980,000 common shares at US$19.00 each, soon after reporting higher quarterly and full-year revenues and declaring a quarterly dividend of US$0.22 per share. The combination of fresh equity capital, a modest dividend increase, and a swing from loss to profit provides new context for how NETSTREIT might fund future property acquisitions and support its income-focused REIT profile. We will...
NasdaqGS:CMPS
NasdaqGS:CMPSBiotechs

A Look At COMPASS Pathways (CMPS) Valuation After Positive COMP360 Phase 3 Results And FDA Plans

Why COMPASS Pathways is back on investor radar COMPASS Pathways (NasdaqGS:CMPS) has attracted fresh attention after reporting highly statistically significant, clinically meaningful Phase 3 results for its COMP360 psilocybin therapy in treatment resistant depression, along with plans to seek a rolling FDA review. See our latest analysis for COMPASS Pathways. The latest COMP360 data and follow on offering come after a sharp 50.96% 90 day share price return and a 112.16% 1 year total...
NasdaqGS:LINC
NasdaqGS:LINCConsumer Services

Lincoln Educational Services (LINC) Margin Rebound Tests Premium P/E Narrative

Lincoln Educational Services (LINC) has put solid numbers on the board for FY 2025, with fourth quarter revenue of US$142.9 million and basic EPS of US$0.41, alongside trailing twelve month revenue of US$518.2 million and EPS of US$0.65. The company has seen quarterly revenue move from US$119.4 million and EPS of US$0.22 in Q4 2024 to US$142.9 million and US$0.41 respectively in Q4 2025, while trailing twelve month EPS moved from US$0.32 to US$0.65 over the same period. This sets the stage...
NYSE:WOR
NYSE:WORMachinery

Worthington Enterprises (WOR) Is Down 5.5% After Scrutiny Of Capital Allocation Intensifies - What's Changed

Worthington Enterprises, a US industrial manufacturer focused on steel processing and pressure cylinders, has recently been criticized for multi‑year declines in annual sales and earnings per share, alongside weakening returns on capital that have raised questions about how effectively management has allocated resources in the past. This deterioration in core financial metrics has sharpened scrutiny of management’s capital deployment choices and their ability to improve the company’s...
NasdaqCM:CRGO
NasdaqCM:CRGOLogistics

Freightos (CRGO) Narrowing Quarterly Losses Tests Bullish Profitability Narrative

Freightos (CRGO) has wrapped up FY 2025 with fourth quarter revenue of US$7.4 million and a basic EPS loss of US$0.07, alongside trailing twelve month revenue of US$29.5 million and a basic EPS loss of US$0.35. Over recent quarters the company has seen quarterly revenue move from US$6.6 million in Q4 2024 to a range between US$6.9 million and US$7.7 million across FY 2025. Quarterly basic EPS losses have sat between US$0.06 and US$0.20, leaving margins still firmly in loss making territory as...
NYSE:SMWB
NYSE:SMWBSoftware

Similarweb (SMWB) Is Down 35.9% After AI Studio Launch And Wider 2025 Losses - What's Changed

In February 2026, Similarweb reported fourth-quarter 2025 revenue of US$72.76 million and a net loss of US$7.5 million, alongside full-year 2025 revenue of US$282.6 million and a net loss of US$32.94 million, while issuing 2026 revenue guidance of US$305.0–US$315.0 million and unveiling its new AI Studio enterprise intelligence platform. The combination of accelerating AI-focused product development, including AI Studio and rising AI-related revenue contributions, with widening losses and...
NasdaqGS:EVRG
NasdaqGS:EVRGElectric Utilities

How Evergy’s Higher Q4 Results And Steady Dividend At Evergy (EVRG) Has Changed Its Investment Story

Evergy, Inc. has declared a quarterly dividend of US$0.6950 per share on its common stock, payable on March 20, 2026 to shareholders of record as of March 10, 2026, and reported fourth-quarter 2025 revenue of US$1,340.2 million and net income of US$84.3 million, both higher than a year earlier. The combination of higher quarterly earnings per share and a maintained cash dividend signals management’s emphasis on returning capital while keeping operating performance on an upward track. Next,...
NYSE:VRE
NYSE:VREResidential REITs

Veris Residential (VRE) One Off Gain Dominates Earnings And Reinforces Bearish Leverage Concerns

Veris Residential (VRE) has wrapped up FY 2025 with Q4 revenue of US$71.3 million, basic EPS near breakeven at about US$0.00, and a small net loss from continuing operations of US$0.4 million, while trailing twelve month EPS stood at US$0.77 on revenue of US$288.4 million. Over recent periods, the company has seen quarterly revenue range from US$68.1 million in Q3 2024 to US$76.4 million in Q2 2025. Basic EPS moved from a loss of US$0.29 on a trailing basis in Q4 2024 to a profit of US$0.77...
NYSE:HG
NYSE:HGInsurance

Is It Too Late To Consider Hamilton Insurance Group (HG) After A 75% One-Year Rally?

If you are wondering whether Hamilton Insurance Group is still attractively priced after its recent run, or if you might be late to the story, this article takes a closer look at what the current share price could be implying about value. The stock last closed at US$30.97, with returns of 0.2% over 7 days, 14.2% over 30 days, 13.6% year to date and 74.6% over the past year. This naturally raises questions about how much of the business outlook might already be reflected in the price. Recent...
NasdaqGM:EYPT
NasdaqGM:EYPTPharmaceuticals

EyePoint (EYPT) Valuation Check As New Chief Commercial Officer Joins Ahead Of Potential DURAVYU Launch

EyePoint (EYPT) shares are in focus after the company named Michael Campbell as Chief Commercial Officer, putting an experienced ophthalmology commercial leader in charge of preparing DURAVYU for potential launch. See our latest analysis for EyePoint. The appointment of Michael Campbell comes after a strong short term share price run, with a 1 day share price return of 11.35% and 7 day share price return of 31.92%. However, the year to date share price return shows a 2.35% decline, which...
NYSE:CDE
NYSE:CDEMetals and Mining

Coeur Mining Results And Deals Reshape Scale Valuation And Governance Outlook

Coeur Mining reported record operational and financial results for 2025, alongside major expansions and acquisitions, including SilverCrest. The company is working toward closing its transaction with New Gold, which is expected to reshape its production profile and asset base. Planned additions of New Gold executives to Coeur’s board point to a shift in governance and integration priorities. Cœur Mining, NYSE:CDE, is drawing fresh attention after these record 2025 results and a series of...
NasdaqGS:NTAP
NasdaqGS:NTAPTech

NetApp’s AI And Hybrid Cloud Gains Meet Recurring Revenue And Valuation Story

NetApp (NasdaqGS:NTAP) reports around 200 AI infrastructure and data lake modernization deals, underscoring traction in AI related workloads. The company sees strong uptake of its hybrid cloud services, including storage-as-a-service offerings. Public cloud and recurring revenues linked to these services are reported to be growing. NetApp, known for its enterprise data storage and management solutions, is leaning into AI infrastructure and hybrid cloud as customers rework how they handle...
NYSE:UE
NYSE:UERetail REITs

Urban Edge Properties (UE) Valuation After Strong Earnings Guidance And 11% Dividend Increase

Urban Edge earnings, guidance, and dividend move into focus Urban Edge Properties (UE) just combined three key updates for investors, reporting full year 2025 results, issuing 2026 earnings guidance, and approving an 11% increase in its indicated annual dividend. See our latest analysis for Urban Edge Properties. Urban Edge Properties' latest earnings, guidance and dividend announcement comes after a steady rebound in the share price, with a 9.4% 30 day share price return and 51.7% three year...
NYSE:AFG
NYSE:AFGInsurance

American Financial Group Results And Guidance Highlight Valuation And Incentive Shifts

American Financial Group, NYSE:AFG, released fresh results alongside updated guidance and continued capital return actions. The company also approved a new long term executive incentive compensation plan focused on performance alignment. These developments provide new information on operating trends and how leadership is being incentivized over time. For shareholders watching NYSE:AFG, the new report and guidance come with some context. The stock closed at $129.61, with a 1 year return of...
NasdaqGS:RUSH.A
NasdaqGS:RUSH.ATrade Distributors

The Bull Case For Rush Enterprises (RUSH.A) Could Change Following Earnings Beat And New Buyback Plan

Rush Enterprises, Inc. recently reported fourth-quarter and full-year 2025 results showing lower year-on-year revenue and earnings, while also completing a US$198.5 million share repurchase under its 2024 authorization and declaring a US$0.19 per-share dividend payable on March 18, 2026 to shareholders of record on March 3, 2026. Alongside earnings that exceeded analyst profit forecasts despite softer truck sales, the company introduced a new US$150 million buyback program, underlining...
NYSE:RSG
NYSE:RSGCommercial Services

Is Republic Services (RSG) Still Fairly Priced After Strong Multi Year Share Gains

If you are wondering whether Republic Services at around US$221 per share still offers fair value, this article will help you size up what you are really paying for. The stock has been relatively steady in the short term, with a 0.9% decline over the last 7 days and a 1.6% return over the last 30 days, while longer term returns of 5.2% year to date, 77.4% over 3 years, and 160.2% over 5 years may catch your eye. Recent news flow around Republic Services has mainly focused on its role in the...
NYSE:WRB
NYSE:WRBInsurance

A Look At W. R. Berkley (WRB) Valuation As Recent Momentum Softens

Event context and recent price performance W. R. Berkley (WRB) shares recently closed at $71.00. The stock showed a small 1 day decline, a roughly 2% move over the past week, and mixed returns over the month and past 3 months. See our latest analysis for W. R. Berkley. Looking beyond the latest move, W. R. Berkley’s 1 year total shareholder return of 17.14% and 5 year total shareholder return of 156.97% contrast with its softer 90 day share price return of an 8.88% decline. This suggests...
NasdaqGS:PRDO
NasdaqGS:PRDOConsumer Services

Perdoceo Results And Augustine Integration Raise Questions On Undervalued Shares

Perdoceo Education (NasdaqGS:PRDO) reported solid Q4 and full year 2025 results, with performance supported by enrollment and revenue trends ahead of prior expectations. The company highlighted progress integrating the University of St. Augustine for Health Sciences, which is contributing to overall operations. Management reiterated its focus on shareholder returns through ongoing share repurchases and dividend payments. For investors following education stocks, Perdoceo Education stands...
NYSE:MOH
NYSE:MOHHealthcare

Molina Healthcare’s Medicaid Profit Worries Test Earnings Story And Outlook

Molina Healthcare (NYSE:MOH) reported mixed fourth quarter results, with revenue growth but an adjusted loss per share that missed expectations. Retroactive revenue items affected the quarter, complicating the picture around the stability of Medicaid related earnings. Management guidance pointed to declining premium revenue and EPS in 2026, with expectations for recovery in 2027. Following the update, several analysts downgraded the stock and highlighted concerns about the company’s ability...